Additionally, future studies should investigate the long-term effects of microbiome-based interventions and explore the potential of personalized medicine approaches tailored to individual patients gut microbial profiles (Cunningham et al., 2021)
Harada M, Miyagawa K, Honma Y, et al
25+ Key Opinion Leaders (KOLs) were contacted for insights on Glucagon-like Peptide-1 (GLP-1) Agonists incorporation in the evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, drug uptake, along with challenges related to accessibility
Calculate Weight Loss Costs Near You** Explore costs in your area Weight Loss Locations Near You CareCredit is accepted through a national network of more than 285,000 healthcare provider, retail and select national health system & hospital locations